|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.810 AUD | -0.71% |
|
+2.18% | -32.61% |
| Jun. 17 | Clarity Pharmaceuticals Enters into a Commercial Manufacturing Agreement with SpectronRx | CI |
| Jun. 16 | Clarity Pharmaceuticals Signs Manufacturing Deal for Diagnostic Product; Shares Rise 5% | MT |
| Capitalization | 909M 596M 510M 476M 440M 816M 51.15B 5.69B 2.17B 23.9B 2.24B 2.19B 87.35B | P/E ratio 2025 * |
-16.9x | P/E ratio 2026 * | -11.8x |
|---|---|---|---|---|---|
| Enterprise value | 848M 557M 476M 444M 410M 762M 47.73B 5.31B 2.03B 22.3B 2.09B 2.04B 81.51B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | 1,080x |
| Free-Float |
73.99% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -0.71% | ||
| 1 week | +2.18% | ||
| Current month | +12.40% | ||
| 1 month | +17.57% | ||
| 3 months | +69.79% | ||
| 6 months | -27.39% | ||
| Current year | -32.61% |
| 1 week | 2.58 |  | 3 |
| 1 month | 1.97 | | 3.05 |
| Current year | 1.43 | | 4.69 |
| 1 year | 1.43 | | 8.98 |
| 3 years | 0.53 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 2024-10-10 |
Matthew Harris
CEO | Chief Executive Officer | - | 2009-12-31 |
| Director of Finance/CFO | - | 2022-04-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 2013-10-31 |
| Director/Board Member | - | 2010-09-30 | |
Chris Roberts
BRD | Director/Board Member | 71 | 2016-03-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.71% | +2.18% | -44.79% | +410.91% | 601M | ||
| -1.01% | +2.87% | +11.77% | +33.47% | 34.72B | ||
| -0.90% | +2.35% | +32.99% | -32.34% | 28.05B | ||
| +9.99% | +9.09% | +105.51% | -29.99% | 28B | ||
| -0.60% | +12.07% | +191.94% | +2,434.00% | 19.22B | ||
| +1.85% | +1.60% | +27.87% | +322.75% | 18.36B | ||
| -1.18% | +6.12% | -23.36% | -44.81% | 13.43B | ||
| +3.70% | +3.29% | +150.00% | -66.69% | 13.32B | ||
| +4.52% | +6.69% | +203.08% | +361.10% | 12.38B | ||
| +0.04% | +2.15% | +100.04% | +118.66% | 12.32B | ||
| Average | +1.56% | +5.38% | +75.50% | +350.71% | 18.04B | |
| Weighted average by Cap. | +1.83% | +5.62% | +77.02% | +314.91% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | 770K 505K 432K 403K 373K 691K 43.32M 4.82M 1.84M 20.24M 1.89M 1.86M 73.99M |
| Net income | -54.2M -35.57M -30.44M -28.36M -26.23M -48.68M -3.05B -339M -130M -1.43B -133M -131M -5.21B | -81.84M -53.71M -45.96M -42.82M -39.6M -73.51M -4.61B -512M -196M -2.15B -201M -197M -7.87B |
| Net Debt | -60.75M -39.87M -34.11M -31.79M -29.4M -54.56M -3.42B -380M -145M -1.6B -150M -146M -5.84B | -77.15M -50.64M -43.33M -40.37M -37.34M -69.3M -4.34B -483M -184M -2.03B -190M -186M -7.42B |
More financial data
* Estimated data
Employees
50
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-11 | 2.810 $ | -0.71% | 2,581,754 |
| 25-07-10 | 2.830 $ | +2.17% | 2,681,063 |
| 25-07-09 | 2.770 $ | +4.92% | 1,540,639 |
| 25-07-08 | 2.640 $ | -4.00% | 1,882,933 |
| 25-07-07 | 2.750 $ | -6.46% | 2,205,561 |
Delayed Quote Australian S.E., July 11, 2025 at 02:10 am EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.830AUD
Average target price
6.658AUD
Spread / Average Target
+135.27%
Annual profits - Rate of surprise
- Stock Market
- Equities
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
